You have 9 free searches left this month | to do more

arn-509

Arn 509 is a drug used to treat Prostate Cancer, Androgen Antagonists, Healthy, and other conditions. Arn 509 is being actively studied in 4 studies and prior, has been studied in 2.

Top SponsorsTop SitesTop Investigators
Aragon Pharmaceuticals, Inc.Barbara Ann Karmanos Cancer InstituteDaniel George, MD
Daniel George, MDChesapeake Urology Associates
Memorial Sloan Kettering Cancer CenterDuke Cancer Center Cary
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
A
Active, not recruiting
  • Prostate Cancer
  • ARN-509
  • +2 more
  • Boston, Massachusetts
    (unnamed)
2021-10-07
Oct 7, 2021
U
Recruiting
  • Prostate Cancer
  • +3 more
  • ARN-509
  • +2 more
  • Leuven, Vlaams-brabant, Belgium
    University Hospitals Leuven
2020-12-23
Dec 23, 2020
M
Active, not recruiting
  • Prostate Cancer
  • ARN-509
  • +3 more
  • Baltimore, Maryland
  • +10 more
2021-02-08
Feb 8, 2021
D
Active, not recruiting
  • Prostate Cancer
  • ARN-509
  • +2 more
  • New Orleans, Louisiana
  • +13 more
2021-02-10
Feb 10, 2021
A
Completed
  • Healthy
  • ARN-509
  • Groningen, Netherlands
    PRA - Clinical Research Unit, University Medical Centre Groninge
2013-09-12
Sep 12, 2013